This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mugge, A. Articles by Harrison, D. G. Search for Related Content PubMed PubMed Citation Articles by Mugge, A. Articles by Harrison, D. G.

Circulation, Vol 83, 1404-1409, Copyright © 1991 by American Heart Association

ARTICLES

Release of nitrogen oxides from cultured bovine aortic endothelial cells is not impaired by calcium channel antagonists

A Mugge, T Peterson and DG Harrison
Department of Internal Medicine, University of Iowa Hospital and Clinics, Iowa City.

BACKGROUND. The endothelium-derived relaxing factor has been shown to be nitric oxide or a related nitroso compound, synthesized by the enzyme nitric oxide synthetase, which oxidizes the guanidono nitrogens of arginine. This enzyme is activated by increases in cytosolic calcium. The effect of the clinically used calcium channel antagonists on this process is controversial. The present study was performed to determine whether calcium channel blockade with these pharmacologic agents would alter the activity of nitric acid synthetase in intact endothelial cells. METHODS AND RESULTS. A specific and sensitive chemiluminescence assay was used to measure the release of nitrogen oxides (nitric oxide and one-electron oxidation products of nitric oxide) from bovine aortic endothelial cells grown in culture. Under basal conditions, the release of nitrogen oxides was about 0.2 nmol/100 micrograms protein/hr. Bradykinin doubled this response. Removal of extracellular calcium abolished basal and bradykinin-stimulated release of nitrogen oxides. Neither diltiazem, verapamil, nor nifedipine in concentrations that are encountered clinically altered the release of nitrogen oxides. CONCLUSIONS. These experiments show that although the production of nitrogen oxides is dependent on extracellular calcium, the clinically used calcium channel antagonists do not inhibit the release of the endothelium-derived relaxing factor.

This article has been cited by other articles:

				M. Ozaki, S. Kawashima, T. Hirase, T. Yamashita, M. Namiki, N. Inoue, K.-i. Hirata, and M. Yokoyama Overexpression of Endothelial Nitric Oxide Synthase in Endothelial Cells Is Protective against Ischemia-Reperfusion Injury in Mouse Skeletal Muscle Am. J. Pathol., April 1, 2002; 160(4): 1335 - 1344. [Abstract] [Full Text] [PDF]

				V. Brovkovych, L. Kalinowski, R. Muller-Peddinghaus, and T. Malinski Synergistic Antihypertensive Effects of Nifedipine on Endothelium : Concurrent Release of NO and Scavenging of Superoxide Hypertension, January 1, 2001; 37(1): 34 - 39. [Abstract] [Full Text] [PDF]

				S. B. Mustafa and M. S. Olson Effects of calcium channel antagonists on LPS-induced hepatic iNOS expression Am J Physiol Gastrointest Liver Physiol, August 1, 1999; 277(2): G351 - G360. [Abstract] [Full Text] [PDF]

				S. Ramasamy, G. R. Drummond, J. Ahn, M. Storek, J. Pohl, S. Parthasarathy, and D. G. Harrison Modulation of Expression of Endothelial Nitric Oxide Synthase by Nordihydroguaiaretic Acid, a Phenolic Antioxidant in Cultured Endothelial Cells Mol. Pharmacol., July 1, 1999; 56(1): 116 - 123. [Abstract] [Full Text]

				X. Zhang, F. A. Recchia, R. Bernstein, X. Xu, A. Nasjletti, and T. H. Hintze Kinin-Mediated Coronary Nitric Oxide Production Contributes to the Therapeutic Action of Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitors and Amlodipine in the Treatment in Heart Failure J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 742 - 751. [Abstract] [Full Text]

				S. Ramasamy, S. Parthasarathy, and D. G. Harrison Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid J. Lipid Res., February 1, 1998; 39(2): 268 - 276. [Abstract] [Full Text]

				M. E. Pueyo, J.-F. Arnal, J. Rami, and J.-B. Michel Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells Am J Physiol Cell Physiol, January 1, 1998; 274(1): C214 - C220. [Abstract] [Full Text] [PDF]

				H. Iwatsubo, M. Nagano, T. Sakai, K. Kumamoto, R. Morita, J. Higaki, T. Ogihara, and T. Hata Converting Enzyme Inhibitor Improves Forearm Reactive Hyperemia in Essential Hypertension Hypertension, January 1, 1997; 29(1): 286 - 290. [Abstract] [Full Text] [PDF]

				R. A. Cohen and P. M. Vanhoutte Endothelium-Dependent Hyperpolarization : Beyond Nitric Oxide and Cyclic GMP Circulation, December 1, 1995; 92(11): 3337 - 3349. [Full Text]

				N. Inoue, R. C. Venema, H. S. Sayegh, Y. Ohara, T. J. Murphy, and D. G. Harrison Molecular Regulation of the Bovine Endothelial Cell Nitric Oxide Synthase by Transforming Growth Factor–ß1 Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1255 - 1261. [Abstract] [Full Text]

				Y. Ohara, H. S. Sayegh, J. J. Yamin, and D. G. Harrison Regulation of Endothelial Constitutive Nitric Oxide Synthase by Protein Kinase C Hypertension, March 1, 1995; 25(3): 415 - 420. [Abstract] [Full Text]